INCREASE trialNSCLCipilimumab/nivolumabT3-4N0-2 non-small cell lung cancerIPI/NIVO
…ohort study collected TDLN from 2 groups: (1) patients from the INCREASE trial who were treated with neoadjuvant ipilimumab/nivolumab (IPI/NIV…
1articles mentioning institutions
1institution mentions
1distinct institutions extracted
0%of mentions human-reviewed
Active filtersEntity: INCREASE trial ×
INCREASE trial
This institution is selected. Its supporting articles are shown below.